Read more posts

Related posts

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Patient insights to shape development of a dCBT for IPF patients

Idiopathic Pulmonary Fibrosis: 5 Things to Know

Top line data on the ATTRACT study

C21 shows promise against COVID-19 where other drugs have failed